阿育吠陀药物的科学评价-使用N-of-1临床试验

Arani Chatterjee, Swaminathan Subramaniam, Sankaranarayanan A
{"title":"阿育吠陀药物的科学评价-使用N-of-1临床试验","authors":"Arani Chatterjee, Swaminathan Subramaniam, Sankaranarayanan A","doi":"10.20529/ijme.2023.067","DOIUrl":null,"url":null,"abstract":"Despite its ancient roots and prominence in India as an accepted alternative to modern medicine, Ayurveda’s growth has been hampered by an inability to carry out clinical studies of its effectiveness and safety using modern scientific methods ― while preserving the core of Ayurveda, which is personalised medicine. In this comment, we propose that the N-of-1 trial be used as a practical method to evaluate Ayurvedic treatments, which is simultaneously consistent with the canons of modern medicine and of Ayurveda. We emphasise the importance of doing this as a practical alternative that will benefit patients. We need not wait to resolve the epistemic inconsistency between Ayurveda and modern medicine to take steps in this direction.","PeriodicalId":35523,"journal":{"name":"Indian journal of medical ethics","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Scientific evaluation of Ayurvedic drugs — the use of N-of-1 clinical trials\",\"authors\":\"Arani Chatterjee, Swaminathan Subramaniam, Sankaranarayanan A\",\"doi\":\"10.20529/ijme.2023.067\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Despite its ancient roots and prominence in India as an accepted alternative to modern medicine, Ayurveda’s growth has been hampered by an inability to carry out clinical studies of its effectiveness and safety using modern scientific methods ― while preserving the core of Ayurveda, which is personalised medicine. In this comment, we propose that the N-of-1 trial be used as a practical method to evaluate Ayurvedic treatments, which is simultaneously consistent with the canons of modern medicine and of Ayurveda. We emphasise the importance of doing this as a practical alternative that will benefit patients. We need not wait to resolve the epistemic inconsistency between Ayurveda and modern medicine to take steps in this direction.\",\"PeriodicalId\":35523,\"journal\":{\"name\":\"Indian journal of medical ethics\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-11-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Indian journal of medical ethics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.20529/ijme.2023.067\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian journal of medical ethics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20529/ijme.2023.067","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

尽管阿育吠陀在印度有着古老的根源,并作为一种被接受的现代医学替代品而受到重视,但由于无法使用现代科学方法对其有效性和安全性进行临床研究,同时保留阿育吠陀的核心,即个性化医学,它的发展受到了阻碍。在这篇评论中,我们建议将N-of-1试验作为一种实用的方法来评估阿育吠陀疗法,这同时符合现代医学和阿育吠陀的经典。我们强调这样做的重要性,作为一种实用的替代方案,将使患者受益。我们不需要等到解决阿育吠陀和现代医学之间的认知不一致,才朝着这个方向迈出一步。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Scientific evaluation of Ayurvedic drugs — the use of N-of-1 clinical trials
Despite its ancient roots and prominence in India as an accepted alternative to modern medicine, Ayurveda’s growth has been hampered by an inability to carry out clinical studies of its effectiveness and safety using modern scientific methods ― while preserving the core of Ayurveda, which is personalised medicine. In this comment, we propose that the N-of-1 trial be used as a practical method to evaluate Ayurvedic treatments, which is simultaneously consistent with the canons of modern medicine and of Ayurveda. We emphasise the importance of doing this as a practical alternative that will benefit patients. We need not wait to resolve the epistemic inconsistency between Ayurveda and modern medicine to take steps in this direction.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Indian journal of medical ethics
Indian journal of medical ethics Medicine-Medicine (all)
CiteScore
2.40
自引率
0.00%
发文量
96
期刊介绍: The Indian Journal of Medical Ethics (formerly Issues in Medical Ethics) is a platform for discussion on health care ethics with special reference to the problems of developing countries like India. It hopes to involve all cadres of, and beneficiaries from, this system, and strengthen the hands of those with ethical values and concern for the under-privileged. The journal is owned and published by the Forum for Medical Ethics Society, a not-for-profit, voluntary organisation. The FMES was born out of an effort by a group of concerned doctors to focus attention on the need for ethical norms and practices in health care.
期刊最新文献
Towards Universal Health Coverage — A contribution to the debate Dr Marthanda Varma Sankaran Valiathan (1934-2024) Kaala Paani and epidemic ethics: hit or miss? Surfactants and the importance of informed consent: Nurturing culturally competent care in healthcare settings Reflections on the Kerala Public Health Act 2023: A response to Dr Karpagam’s commentary
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1